carboplatin,pemetrexed,durvalumab,paclitaxel,sd-101,relatlimab,cisplatin,nivolumab,gemcitabine,ipilimumab,pembrolizumab,Toripalimab,Vinorelbine,Docetaxel,Atezolizumab
astrazeneca,merck,bms,trisalus life sciences,Coherus,Junshi Biosciences,Roche
['aegean', 'kn671', 'ts,perio,1', 'ts,perio,i', 'lcsm,(-blcsm)']
impressive talk by os (interim) favors periop tx pcr ~ 17-18% w/ aegean &amp; kn671 need approaches for pts who don t achieve pcr/mpr, benefit of adj io unclear egfr/alk #lcsm #asco23 
Leslye M. Heisler Associate Professor of Lung Cancer Excellence @PennMedicine | AD @PC31 | Incoming Chair @ASCO #CCC | Tweets my own | COI: https://t.co/ghKU8KhBvl